Vertex Pharmaceuticals Inc.is set to buy ViaCyte, a cell therapy startup specializing in diabetes, for $320 million cash.
Gary Higgins / Boston Business Journal
Check out the 10 mergers and acquisitions of tech and life sciences companies we reported on in July.
- Boston-based GoTo announced it plans to acquire cloud-based device management provider Miradore from Nordic technology investor Standout Capital and its other stakeholders. Terms were not disclosed.
- Cambridge-based Syros Pharmaceuticals has agreed to acquire a New Jersey biotech firm called Tyme Technologies Inc. Syros will spend about $60 million to purchase the company.
- ASGN Inc., an IT services company based in Virginia, closed its $350 million acquisition of Waltham-based GlideFast Consulting LLC.
- A fund managed by BlackRock Real Assets has acquired Vanguard Renewables from Vision Ridge Partners. The company's CEO Neil Smith said this deal will help it achieve its goal of building around 150 digester sites across the U.S. in the next few years. The deal was valued at around $700 million, a person familiar with the transaction confirmed to BostInno.
- Ginkgo Bioworks Holdings Inc. is set to take over one of its competitors, Zymergen Inc., in its largest acquisition to date. The all-stock transaction values Zymergen, a California company, at $300 million.
- New York-based FemTec Health announced its acquisition of Nutrimedy, a clinical nutrition company with offices in Brookline and Worcester. Terms were not disclosed.
- Recent unicorn airSlate Inc. has acquired DocHub, an online PDF editor and document signing company. Terms were not made public.
- Bedford-based AspenTech is buying Micromine, a provider of design and operational management software for the mining industry, for approximately $623 million.
- Vertex Pharmaceuticals Inc.is set to buy ViaCyte, a cell therapy startup specializing in diabetes, for $320 million cash.
- Innoviva Inc. will pay about $149 million for infectious diseases firm La Jolla Pharmaceutical Company.
